According to Anika Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 14,635,000. At the end of 2023 the company had 14,635,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 14.63 M | -0.03% |
2022 | 14.64 M | 1.4% |
2021 | 14.43 M | 1.14% |
2020 | 14.27 M | -0.04% |
2019 | 14.28 M | 0.79% |
2018 | 14.16 M | -2.93% |
2017 | 14.59 M | 0.4% |
2016 | 14.53 M | -2.85% |
2015 | 14.96 M | 1.11% |
2014 | 14.8 M | 3.7% |
2013 | 14.27 M | 7.11% |
2012 | 13.32 M | 3.96% |
2011 | 12.81 M | 1.46% |
2010 | 12.63 M | 10.96% |
2009 | 11.38 M | 0.5% |
2008 | 11.32 M | 1.58% |
2007 | 11.15 M | 4.46% |
2006 | 10.67 M | 1.85% |
2005 | 10.48 M | 3.37% |
2004 | 10.14 M | 1.82% |
2003 | 9.95 M | 0.26% |
2002 | 9.93 M | 0% |
2001 | 9.93 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 16,348.24% | ๐บ๐ธ USA |
Medtronic MDT | 1,329,700,000 | 8,985.75% | ๐ฎ๐ช Ireland |
Stryker Corporation SYK | 380,000,000 | 2,496.52% | ๐บ๐ธ USA |
STAAR Surgical STAA | 48,613,000 | 232.17% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | 131,965,000 | 801.71% | ๐บ๐ธ USA |
Hill-Rom HRC | 66,555,500 | 354.77% | ๐บ๐ธ USA |